| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |